Amid asset sale speculation and the cycle of earnings season, analysts from Mizuho, Maxim, and Merrill Lynch are offering insights into the key …
Oculus Innovative, Sciences, Inc. (NASDAQ:OCLS) shares were sent climbing 26% yesterday after the specialty pharmaceutical company announced the sale of its Latin America …
As the biotech community debates Opexa Therapeutics Inc’s (NASDAQ:OPXA) clinical trial setback in Secondary Progressive Multiple Sclerosis (SPMS), Maxim analyst Jason McCarthy added further fuel to …
Galena Biopharma Inc (NASDAQ:GALE) shares are climbing almost 12% today after the biotech firm presented data from its Phase 1b trial that evaluates patient’s …
In a research report published Monday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Omeros Corporation (NASDAQ:OMER) with a price target of …
In a research report issued Monday, Maxim analyst Jason McCarthy reiterated a Buy rating on Galena Biopharma Inc (NASDAQ:GALE) with a price target of …
Anavex Life Sciences Corp. (NASDAQ:AVXL) announced that its oral pipeline drug candidate 2-73, developed to potentially modify Alzheimer’s disease rather than just temporarily …
Maxim analyst Jason McCarthy is out with a research report on shares of bluebird bio Inc (NASDAQ:BLUE) discussing the aftermath of Mast Therapeutics’ (NYSEMKT:MSTX) …
Mast Therapeutics Inc (NYSEMKT:MSTX) announced yesterday that its phase III EPIC study results proved to be a “surprising disappointment,” after the firm’s pipeline …
Tobira Therapeutics Inc (NASDAQ:TBRA) shares are on fire this Tuesday, jumping over 700%, following the news that the company entered into a definitive agreement …
